Ngm Biopharmaceuticals Inc

DEUTSCHE BANK AG\

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

212,944

Value ($000)

183

Weight

0.0%

2019 Q4 - 2023 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	183	0.0%	212,944	12/31/2023
2023 Q2	8/14/2023	601	0.0%	231,917	6/30/2023
2023 Q1	5/15/2023	973	0.0%	238,516	3/31/2023
2022 Q4	2/13/2023	1,224	0.0%	243,855	12/31/2022
2022 Q3	11/14/2022	3,439	0.0%	262,851	9/30/2022
2022 Q2	8/11/2022	3,384	0.0%	263,912	6/30/2022
2022 Q1	5/13/2022	2,622	0.0%	171,894	3/31/2022
2021 Q4	2/16/2022	2,979	0.0%	168,244	12/31/2021
2021 Q3	11/4/2021	3,705	0.0%	176,235	9/30/2021
2021 Q2	8/11/2021	3,014	0.0%	152,854	6/30/2021
2021 Q1	5/13/2021	7,694	0.0%	264,702	3/31/2021
2020 Q4	2/16/2021	539	0.0%	17,776	12/31/2020
2020 Q3	11/12/2020	207	0.0%	12,990	9/30/2020
2020 Q2	8/13/2020	234	0.0%	11,854	6/30/2020
2020 Q1	5/14/2020	121	0.0%	9,797	3/31/2020
2019 Q4	2/14/2020	165	0.0%	8,978	12/31/2019